Treatment of COVID-19 patients with quercetin: a prospective, single center, randomized, controlled trial
Article
[키워드] acute respiratory syndrome
Adjustment
anorexia
baseline
Bioavailability
Bromelain
Care
chill
chronic disease
cohort study
Comorbidity
cough
COVID-19
COVID-19 patient
CRP
curative treatment
death
decrease
demographic
did not reduce
different dose
discharge
distress
Drug administration
Endpoint
evaluate the effect
event
fatigue
Favipiravir
Features
ferritin level
Follow-up
follow-up period
Frequency
group
had more
Hospital admission
increase in
intubation
Laboratory
laboratory result
lung
Lymphocyte count
no difference
parameters
Patient
plasma
Platelet
positive
quercetin
Randomized
randomized, controlled trial
required
Research
respiratory symptoms
risk
routine
SARS CoV-2
SARS-CoV-2
shown
single center
statistically significant
Therapeutic approach
therapeutic strategy
Treatment
Vitamin C
were recorded
while
[DOI] 10.3906/biy-2104-16 PMC 바로가기 [Article Type] Article
[DOI] 10.3906/biy-2104-16 PMC 바로가기 [Article Type] Article